Frazier Lifesciences Acquisition Corporation Warrant
FLACW
FLACW was delisted on the 22nd of November, 2022.
21 hedge funds and large institutions have $2.6M invested in Frazier Lifesciences Acquisition Corporation Warrant in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 12 closing their positions.
62% more capital invested
Capital invested by funds: $1.6M → $2.6M (+$997K)
30% less funds holding
Funds holding: 30 → 21 (-9)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
PEAK6 Investments
Chicago,
Illinois
|
+$25.4K |
| 2 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$15.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12.1K |
| 4 |
Walleye Capital
New York
|
+$3.13K |
| 5 |
Walleye Trading
New York
|
+$1.76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$85.4K |
| 2 |
MA
MYDA Advisors
Woodmere,
New York
|
-$17.6K |
| 3 |
DCM
DG Capital Management
New York
|
-$11K |
| 4 |
CAC
Cowen and Company
New York
|
-$10K |
| 5 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$8.46K |
FLACW Hedge Fund Activity: Q3 2022 in Review
21 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Warrant (FLACW) for Q3 2022, worth a combined $2.6M — up 62% from $1.6M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of FLACW and 4 opened new positions — a net loss of 8 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was PEAK6 Investments, opening a new position worth an estimated $25.4K. The largest seller was Goldman Sachs, cutting an estimated $85.4K.
- 21 institutional investors held Frazier Lifesciences Acquisition Corporation Warrant (FLACW) as of Q3 2022, down from 30 in Q2 2022.
- Funds reported $2.6M of Frazier Lifesciences Acquisition Corporation Warrant stock for Q3 2022, up 62% quarter-over-quarter.
- 4 funds opened new Frazier Lifesciences Acquisition Corporation Warrant positions in Q3 2022 and 12 closed out, a net change of -8 holders.
- The largest Frazier Lifesciences Acquisition Corporation Warrant buyer in Q3 2022 was PEAK6 Investments, an estimated $25.4K added.
- The largest Frazier Lifesciences Acquisition Corporation Warrant seller in Q3 2022 was Goldman Sachs, an estimated $85.4K sold.
Based on aggregated 13F filings for Q3 2022.